1. Search Result

Search Result

Targets Recommended: CRISPR/Cas9

Results for "156294-36-9" in MCE Product Catalog:

Cat. No. Product Name Target Research Area
  • HY-125374


    Apoptosis Cancer
    Larotaxel (XRP9881) is a taxane analogue with preclinical activity against taxane-resistant breast cancer. Larotaxel (XRP9881) exerts its cytotoxic effect by promoting tubulin assembly and stabilizing microtubules, ultimately leading to cell death by apoptosis. It presents the ability to cross the blood brain barrier and has a much lower affinity for P-glycoprotein 1 than Docetaxel.